Sita Patel

Sita Patel

Active Director Director DIN 03398037
DIN 03398037 First appointment Feb 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2011
Shareholding value •••• Premium profile

About Sita Patel

Data last updated:

Sita Patel is a Director at Conset Pharma Private Limited (since 2011). The company operates in Pharma. Conset Pharma Private Limited reported revenue of ₹2.69 Cr (FY 2024).

DIN 03398037
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2011
Oldest Company Age 15 yrs
Largest company Conset Pharma Private Limited · ₹2.69 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Conset Pharma Private Limited U51397MP2011PTC025290
Director01 Feb 20112011₹2.69 Cr (FY 2024)Active

Board colleagues of Sita Patel

NameDINCompanyDesignation
Deepak Patel08177653Conset Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Conset Pharma Private Limited
Premium access

Shareholding and investment profile for Sita Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sita Patel

Sita Patel currently holds 1 directorship: Conset Pharma Private Limited (Director, since 01 Feb 2011, revenue ₹2.69 Cr (FY 2024)).

Sita Patel was first appointed on 01 Feb 2011 as Director at Conset Pharma Private Limited.

The current boards of Sita Patel's companies include Deepak Patel (Conset Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available